Literature DB >> 3752463

The work of the Leeds Malignant Hyperpyrexia Unit, 1971-84.

F R Ellis, P J Halsall, D G Harriman.   

Abstract

A detailed account of the procedure of muscle biopsy for screening patients suspected of being susceptible to malignant hyperpyrexia is given, together with a review of the results obtained from 1127 patients screened over the last 14 years. The information should help anaesthetists to discuss the investigation fully with probands and other members of their families before referral for further specific investigation.

Entities:  

Mesh：

Year:  1986        PMID： 3752463     DOI： 10.1111/j.1365-2044.1986.tb13122.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN： 0003-2409            Impact factor:   6.955


  5 in total

1.  Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1.

Authors:  J R Lopez; V Kaura; C P Diggle; P M Hopkins; P D Allen
Journal:  Br J Anaesth       Date:  2018-08-10       Impact factor: 9.166

2.  Genetic heterogeneity and HOMOG analysis in British malignant hyperthermia families.

Authors:  R Robinson; J L Curran; W J Hall; P J Halsall; P M Hopkins; A F Markham; A D Stewart; S P West; F R Ellis
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

Review 3.  The genetics of malignant hyperthermia.

Authors:  S P Ball; K J Johnson
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

Review 4.  Adverse effects of general anaesthetics.

Authors:  M C Berthoud; C S Reilly
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

5.  C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response.

Authors:  M Steinfath; S Singh; J Scholz; K Becker; C Lenzen; F Wappler; A Köchling; N Roewer; J Schulte am Esch
Journal:  J Mol Med (Berl)       Date:  1995-01       Impact factor: 4.599
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.